Watch Demo

Belgium Analgesic Industry Outlook 2022 - 2026

See how Belgium Analgesic performed compared to key markets such as Germany, Spain and Canada.

Key Market Indicators

Belgian analgesic medicine sales are expected to reach $296.28 million by 2026. This is a 0.3% annual growth rate from 2021's sales of $299.42 million. Since 2007, the market has grown an average of 1.9% each year. In 2021, Belgium ranked 7th globally in analgesic sales. Australia overtook the country with $299.42 million. Spain, Canada and Italy ranked 2nd, 3rd and 4th respectively.

Marketing Banner

Belgium Analgesic Market Data and Forecasts

How much will Belgium Analgesic Market grow to 2026?

Forecast: Analgesic Medicine Sales in Belgium
Forecast: Analgesic Medicine Use in Belgium
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Use in Belgium
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Belgium
Forecast: Analgesic Medicine Sales in Belgium
More in Analgesic Industry for 2028

Improve your Knowledge with the latest Indicators and Trends